Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: Neuro-panacea

Neurological Research

Volumn 28, Issue 4, 2006, Pages 431-435

  Wong, George K C ^a   Chan, Matthew T V ^a   Poon, Wai S ^a   Boet, Ronald ^a   Gin, Tony ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebral vasospasm; Intracranial aneurysm; Magnesium; Subarachnoid hemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ION; EXCITATORY AMINO ACID; MAGNESIUM; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; PAPAVERINE; PLACEBO;

ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN VASOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROCYTE DEFORMABILITY; HUMAN; INTENSIVE CARE; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NERVE CELL LESION; NONHUMAN; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RAT; REVIEW; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; HUMANS; MAGNESIUM SULFATE; SUBARACHNOID HEMORRHAGE; TIME FACTORS;

EID: 33745653507     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X115035     Document Type: Review

References (28)

1. Rinkel GJE, Feigin VL, Algra A, et al. Calcium antagonists in aneurysmal subarachnoid hemorrhage. Stroke 2005; 36: 1816-1817
2. Roos YB, Levi M, Carroll TA, et al. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001; 32: 1860-1862
3. Ustun ME, Bariskaner H, Yosunkaya A, et al. Effects of magnesium sulfate on Na+,K+-ATPase and intracranial pressure level after cerebral ischemia. Megnes Res 2004; 17: 169-175
4. Rasmussen HS, Gronbaek M, Cintin C, et al. One-year death rate in 270 patients with suspected acute myocardial infarction initially treated with intravenous magnesium or placebo. Clin Cardiol 1988; 11: 377-381
5. Shechter M, Hod H. Magnesium therapy in aged patients with acute myocardial infarction. Magnes Bull 1991; 13: 7-9
6. Woods KL, Fletcher S, Roffe C, et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-1558
7. Alghamdi AA, Al-Radi OO, Latter DA. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: A systematic review and meta-analysis. J Card Surg 2005; 20: 293-299
8. Fagan TE, Scarpa A. Hormone-stimulated Mg(2+) accumulation into rat hepatocytes: A pathway for rapid Mg(2+) and Ca(2+) redistribution. Arch Biochem Biophys 2002; 401: 277-282
9. van den Bergh WM, Algra A, van der Sprenkel JW, et al. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52: 276-281
10. Lampl Y, Geva D, Gilad R, et al. Cerebrospinal fluid magnesium level as a prognostic factor in ischemic stroke. J Neurol 1998; 245: 584-588
11. Belfort MA, Anthony J, Saade GR, et al. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348: 304-311
12. Schauf B, Becker S, Abele H, et al. Effect of magnesium on red blood cell deformability in pregnancy. Hypertens Pregnancy 2005; 24: 17-27
13. Pyne GJ, Cadoux-Hudson TA, Clark JF. Magnesium protection against in vitro cerebral vasospasm after subarachnoid hemorrhage. Br J Neurosurg 2001; 15: 409-415
14. Lee EJ, Lee MY, Chang GL, et al. Delayed treatment with magnesium: Reduction of brain infarction and improvement of electrophysiological recovery following transient focal cerebral ischemia in rats. J Neurosurg 2005; 102: 1085-1093
15. Westermaler T, Zausinger S, Baethmann A, et al. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochir (Wien) 2005; 147: 525-532
16. Marinov MB, Harbaugh KS, Hoopes PJ, et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 1996; 85: 117-124
17. Muir KW, Lees KR, Ford I, et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): Randomized controlled trial. Lancet 2004; 363: 439-445
18. Barile M, van De Wynaert F, Mbia JJ, et al. Intravenous magnesium sulfate administration in a patient with refractory vasospasm following subarachnoid hemorrhage. Intensive Care Med 2003; 29: 1182-1185
19. Macdonald RL, Curry DJ, Aihara Y, et al. Magnesium and experimental vasospasm. J Neurosurg 2004; 100: 106-110
20. Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922-927
21. Saver JL, Kidwell C, Eckstein M, et al. Prehospital neuroprotective therapy for acute stroke: Results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004; 35: e106-e108
22. Wong GK, Chan MT, Boet R, et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: A prospective randomized pilot study. J Neurosurg Anesth (In press)
23. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: A pilot study. Neurosurgery 2000; 47: 602-606
24. Chia RY, Hughes RS, Morgan MK. Magnesium: A useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Clin Neurosci 2002; 9: 279-281
25. Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96: 510-514
26. van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled Trial. Stroke 2005; 36: 1011-1015
27. Winter JE, Richey CH. Human absorption of magnesium with and without aspirin and other adjuvants. J Pharmacol Exp Ther 1931; 42: 179-183
28. Wong GK, Boet R, Poon WS, et al. Trial design in 'magnesium sulphate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial'. Stroke 2005; 36: 2530-2531